SEC Filings for Oragenics Inc. (OGEN)

$ 0.7876   0.0203 (+2.65%) Volume: 4.93m 8:00 PM EDT Jul 7, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)3305/15/2018
S-1Registration statement under Securities Act of 19339205/15/2018
424B3Prospectus [Rule 424(b)(3)]7005/08/2018
S-1Registration statement under Securities Act of 19338004/27/2018
PRE 14APreliminary proxy statement providing notification matters to be brought to a vote6204/24/2018
DNotice of Exempt Offering of Securities104/12/2018
8-KCurrent report pursuant to Section 13 or 15(d)8404/10/2018
SC 13GStatement of acquisition of beneficial ownership by individuals104/09/2018
10-KAnnual report pursuant to Section 13 or 15(d)13802/16/2018
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans802/16/2018
SC 13D/A[Amend] General statement of acquisition of beneficial ownership1302/14/2018
8-KCurrent report pursuant to Section 13 or 15(d)401/19/2018
2345678910111213141516